HPA Axis

Overview

The hypothalamic-pituitary-adrenal (HPA) axis is the body's central stress response system — a neuroendocrine cascade that translates perceived threats, physical stressors, and inflammatory signals into a coordinated hormonal response centered on cortisol production from the adrenal glands. Beyond acute stress management, the HPA axis maintains basal cortisol rhythms that regulate metabolism, immune function, cardiovascular tone, and cognitive processing throughout the day.

In peptide research, the HPA axis is relevant for several reasons: ACTH, the central signaling hormone of this axis, is itself a peptide derived from the POMC precursor (shared with the melanocortin system); cortisol output profoundly influences tissue repair, immune function, and the activity of other pathways targeted by bioactive peptides; and some growth hormone secretagogues inadvertently stimulate ACTH and cortisol release, an effect that varies by compound and is important for understanding their side-effect profiles.

How It Works

The Hypothalamic Level: CRH and AVP

CRH (Corticotropin-Releasing Hormone)

• A 41-amino acid peptide produced by parvocellular neurons in the paraventricular nucleus (PVN) of the hypothalamus
• Released into the hypothalamic-hypophyseal portal blood system in a pulsatile and circadian pattern
• Binds CRH receptor type 1 (CRH-R1) on corticotroph cells in the anterior pituitary
• The primary driver of ACTH secretion under both basal and stress conditions
• CRH also has direct effects in the brain: it is anxiogenic and activates the sympathetic nervous system

AVP (Arginine Vasopressin)

• Co-released with CRH from PVN neurons during stress
• Acts synergistically with CRH to amplify ACTH release
• Binds V1b (V3) receptors on corticotrophs
• AVP's contribution increases during chronic stress, when CRH receptor desensitization may occur

Circadian regulation: The HPA axis exhibits a robust circadian rhythm driven by the suprachiasmatic nucleus (SCN, the master circadian clock):

• Cortisol peaks in the early morning (6-8 AM), producing the cortisol awakening response (CAR)
• Cortisol reaches its nadir around midnight
• This rhythm is superimposed on ultradian (pulsatile) CRH/ACTH release occurring approximately every 1-2 hours
• Disruption of this rhythm (shift work, jet lag, chronic stress) has significant health consequences

The Pituitary Level: ACTH

ACTH (Adrenocorticotropic Hormone)

• A 39-amino acid peptide cleaved from POMC (pro-opiomelanocortin) in anterior pituitary corticotroph cells
• The same POMC precursor that yields alpha-MSH and beta-endorphin in the melanocortin system
• ACTH acts on MC2R (melanocortin-2 receptor) in the adrenal cortex — the only melanocortin receptor that responds exclusively to ACTH
• ACTH stimulates cortisol synthesis and secretion within minutes through acute StAR protein-mediated cholesterol transport into mitochondria
• ACTH also has trophic effects on the adrenal cortex — chronic ACTH stimulation causes adrenal hypertrophy; chronic ACTH deficiency causes adrenal atrophy
• Half-life: approximately 10 minutes

The Adrenal Level: Cortisol

ACTH binds MC2R (with MRAP accessory protein) on the zona fasciculata of the adrenal cortex, activating a cAMP-PKA signaling cascade that stimulates:

Acute response (minutes):

• StAR (steroidogenic acute regulatory protein) facilitates cholesterol transport from the outer to inner mitochondrial membrane
• This is the rate-limiting step in steroidogenesis

Steroidogenic cascade: Cholesterol → pregnenolone → 17-hydroxypregnenolone → 17-hydroxyprogesterone → 11-deoxycortisol → cortisol

Key enzymes: CYP11A1 (cholesterol side-chain cleavage), CYP17A1 (17α-hydroxylase), CYP21A2 (21-hydroxylase), CYP11B1 (11β-hydroxylase)

Cortisol actions: Cortisol is a glucocorticoid steroid hormone that acts through two nuclear receptors:

• Glucocorticoid receptor (GR) — Widely expressed; activated at higher cortisol concentrations (stress levels). Mediates most of cortisol's stress-response, metabolic, and immunosuppressive effects.
• Mineralocorticoid receptor (MR) — High affinity for cortisol; occupied at basal cortisol levels. Important for circadian regulation and tonic effects in the brain and kidney.

Major cortisol effects include:

• Metabolic — Gluconeogenesis stimulation, protein catabolism, lipolysis, insulin antagonism
• Anti-inflammatory/immunosuppressive — Suppression of NF-kB pathway transcriptional activity, reduced cytokine production, lymphocyte apoptosis, inhibition of JAK-STAT signaling
• Cardiovascular — Vascular reactivity maintenance, blood pressure support
• CNS — Modulation of cognition, mood, arousal; memory consolidation; at chronic high levels, hippocampal damage and cognitive impairment
• Musculoskeletal — Catabolic effects on bone and muscle at supraphysiological levels

Feedback Regulation

Negative feedback: Cortisol exerts negative feedback at multiple levels:

1. Hypothalamus — Cortisol suppresses CRH gene transcription and CRH release via GR activation in PVN neurons
2. Pituitary — Cortisol suppresses POMC gene transcription and ACTH release in corticotrophs
3. Hippocampus — Cortisol activates MR and GR in hippocampal neurons, which send inhibitory projections to the PVN

Both fast (non-genomic, within minutes) and slow (genomic, hours) feedback mechanisms exist, allowing rapid stress termination and sustained tonic regulation.

Key Components

Role in Peptide Research

ACTH and Fragments

ACTH itself and its fragments (ACTH 1-24, known as cosyntropin/tetracosactide) are used clinically in the ACTH stimulation test to diagnose adrenal insufficiency. ACTH 4-10 (a fragment lacking steroidogenic activity) has been studied for cognitive-enhancing effects, suggesting melanocortin receptor-mediated CNS actions independent of cortisol.

Growth Hormone Secretagogues

Different GH secretagogues from the growth hormone axis vary significantly in their HPA axis stimulation:

• GHRP-6 — Stimulates ACTH and cortisol release at higher doses, in addition to GH
• GHRP-2 — Moderate ACTH/cortisol stimulation
• Hexarelin — Notable ACTH/cortisol stimulation
• Ipamorelin — Minimal to no ACTH or cortisol stimulation at standard doses, making it the most selective GH secretagogue with respect to HPA axis preservation
• This selectivity profile is a key differentiator among GHRPs and influences compound selection in research protocols

BPC-157

BPC-157 has been noted in preclinical studies to lack significant interactions with the HPA axis — no reported effects on ACTH or cortisol levels. This absence of HPA axis perturbation is considered a favorable safety characteristic.

CRH Analogs

CRH and its analogs (e.g., corticorelin) are used diagnostically to assess HPA axis function and differentiate between hypothalamic and pituitary causes of ACTH deficiency or excess.

Melanocortin Peptides

Since ACTH is a melanocortin peptide and signals through MC2R, the melanocortin system and HPA axis are molecularly linked. Synthetic melanocortin analogs (melanotan II) that have some MC2R cross-reactivity could theoretically influence adrenal function, though this is not a primary effect at typical research doses.

Clinical Significance

• Cushing's syndrome — Chronic cortisol excess from pituitary ACTH-secreting adenomas (Cushing's disease), ectopic ACTH production, or adrenal tumors. Causes central obesity, diabetes, hypertension, osteoporosis, immunosuppression, and psychiatric disturbances.
• Addison's disease — Primary adrenal insufficiency with cortisol and aldosterone deficiency. Life-threatening without replacement therapy.
• Secondary adrenal insufficiency — Occurs from pituitary ACTH deficiency or, most commonly, from chronic exogenous glucocorticoid use that suppresses the HPA axis. Abrupt glucocorticoid withdrawal can precipitate adrenal crisis.
• Chronic stress and allostatic load — Prolonged HPA axis activation contributes to metabolic syndrome, cardiovascular disease, depression, cognitive decline, and immunosuppression.
• Post-traumatic stress disorder (PTSD) — Characterized by paradoxical HPA axis dysregulation with enhanced negative feedback sensitivity and low cortisol despite high stress reactivity.
• Critical illness — HPA axis dysfunction during sepsis and critical illness (critical illness-related corticosteroid insufficiency) contributes to hemodynamic instability and mortality.

Related Topics

• Melanocortin System — ACTH is a melanocortin peptide; MC2R mediates adrenal cortisol production
• HPG Axis — Cortisol suppresses GnRH pulsatility and reproductive function
• Growth Hormone Axis — Cortisol inhibits GH secretion; some GHRPs stimulate ACTH
• NF-kB Pathway — Cortisol suppresses NF-kB as a primary anti-inflammatory mechanism
• JAK-STAT Pathway — Glucocorticoids inhibit JAK-STAT signaling in immune cells